Real World Data Archives

On-Demand Webinar

ケーススタディを通して見る欧州におけるHTAと市場アクセスの強みと機会

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…

Jim Gallagher2021年5月26日

On-Demand Webinar

Similarities and differences between SNDS and other claim databases

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…

Jim Gallagher2021年5月25日

On-Demand Webinar

Overview of SNDS and the key working practices to access the database and ongoing SNDS developments

Amongst the real world data sources in Europe, the French Healthcare database SNDS is the…

Jim Gallagher2021年5月25日

Brochure

Early Engagement with HTA Bodies

In-depth guide to successful early HTA engagement.

Jim Gallagher2021年5月10日

On-Demand Webinar

Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)

Watch this presentation to learn • Overview of the SNDS and the key working practices…

Jim Gallagher2021年5月7日

Publication

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

Authors: Joseph McGuirk, Clint Divine, Seung Hyun Moon, Aastha Chandak, Zhiji Zhang, Genovefa A. Papanicolaou…

Jim Gallagher2021年4月8日

Article

Legislators: Bring all stakeholders to the table to lower drug costs

BY ROMAN CASCIANO, OPINION CONTRIBUTOR — 03/29/21 05:30 PM EDT No one is happy with the…

Certara2021年3月30日

On-Demand Webinar

Strategic Evidence & Value Communication Symposium

Join us on 2021年4月21日 (水曜日), from12:00 PM – 2:00 PM EDT for Certara’s…

Certara2021年3月26日

Blog

遺伝子治療を患者へ届けるために

This blog discusses the challenges that drug developers face in getting patients access to cell…

Certara2021年2月16日

Case Study

遺伝子治療臨床試験デザインにおける早期価値評価

A global biotechnology company engineering precision genetic medicine for rare diseases was in need of…

Jim Gallagher2021年2月12日

Powered by Translations.com GlobalLink Web Software

Real World Data

ケーススタディを通して見る欧州におけるHTAと市場アクセスの強みと機会

Similarities and differences between SNDS and other claim databases

Overview of SNDS and the key working practices to access the database and ongoing SNDS developments

Early Engagement with HTA Bodies

Evidence generation in Europe- How valuable is the French National administrative health data (SNDS)

Economic and Clinical Burden of Virus-Associated Hemorrhagic Cystitis in Patients Following Allogeneic Hematopoietic Stem Cell Transplantation in the United States

Legislators: Bring all stakeholders to the table to lower drug costs

Strategic Evidence & Value Communication Symposium

遺伝子治療を患者へ届けるために

遺伝子治療臨床試験デザインにおける早期価値評価

メルマガ登録

クイックアクセス

ソリューション

お問合せ